industry
Drug Approval Timeline Same as 20 Years Ago
Drug Approval Timeline Same as 20 Years Ago
Kerry Grens | Jan 9, 2017
A report finds that new medications still take about 12 years to go from patent to patient.
Addressing Biomedical Science’s PhD Problem
Addressing Biomedical Science’s PhD Problem
Catherine Offord | Jan 1, 2017
Researchers and institutions seek to bridge the gap between emerging life science professionals and available positions.
Industry-Funded Sugar Study: Don’t Trust Other Sugar Studies
Industry-Funded Sugar Study: Don’t Trust Other Sugar Studies
Joshua A. Krisch | Dec 21, 2016
Two opposing papers in Annals of Internal Medicine battle over dietary guidelines on sugar.
2016 Salary Survey: By the Numbers
2016 Salary Survey: By the Numbers
The Scientist Staff | Oct 31, 2016
This year's life sciences salary survey turned up some interesting trends in the U.S. and around the world.
Q&A: From FDA to Industry
Q&A: From FDA to Industry
Kerry Grens | Sep 27, 2016
Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.
$1.5 Billion Pharma Buyout for Leukemia Drug
$1.5 Billion Pharma Buyout for Leukemia Drug
Jef Akst | Jun 1, 2016
Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.
Thermo Fisher to Acquire FEI
Thermo Fisher to Acquire FEI
Tracy Vence | Jun 1, 2016
In a $4.2 billion deal, the science equipment giant is buying the Hillsboro, Oregon-based electron microscope maker.
Do Patents Promote or Stall Innovation?
Do Patents Promote or Stall Innovation?
Catherine Offord | Jun 1, 2016
A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.
E.U. Delays Vote on Roundup
E.U. Delays Vote on Roundup
Bob Grant | May 24, 2016
Newly published research on the key ingredient in the Monsanto-made weed killer is holding up lawmakers’ decisions on whether to continue to allow its sale in Europe.
Antibody Maker Loses License Over Animal Welfare Violations
Antibody Maker Loses License Over Animal Welfare Violations
Jef Akst | May 23, 2016
The US Department of Agriculture orders Santa Cruz Biotechnology to pay a $3.5 million fine and to cease selling research antibodies.